Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Cromolyn sodium
Drug ID BADD_D00539
Description A chromone complex that acts by inhibiting the release of chemical mediators from sensitized mast cells. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack.
Indications and Usage For the management of patients with bronchial asthma. Also used in the treatment of vernal keratoconjunctivitis, vernal conjunctivitis, and vernal keratitis.
Marketing Status approved
ATC Code S01GX01; R03BC01; D11AH03; R01AC01; A07EB01
DrugBank ID DB01003
KEGG ID D00526
MeSH ID D004205
PubChem ID 27503
TTD Drug ID D0G7IY
NDC Product Code 38779-0301; 76003-0773; 42571-132; 52183-199; 69784-200; 62255-1321; 73377-119; 50090-3042; 12828-0062; 71205-085; 12780-4960; 42571-350; 48102-033; 53002-0140; 69784-205; 51552-0423; 62991-1038; 66219-0531; 16571-600; 51525-0470; 61314-237; 63629-2483; 17337-0511; 71052-686; 0037-0678; 17478-291; 63629-2485; 49452-0006; 0172-6406; 50090-1202; 57782-397; 51927-5178; 71205-230; 82298-910
UNII Q2WXR1I0PK
Synonyms Cromolyn Sodium | Sodium Cromoglycate | Cromoglycate, Sodium | Disodium Cromoglycate | Cromoglycate, Disodium | Aarane | Bicromat Spray | Cromoglycate | Opticrom | FPL-670 | FPL 670 | FPL670 | Intal | Lomudal | Nalcrom | Nasalcrom | Vicrom | Cromolyn | Cromoglicic Acid | Acid, Cromoglicic | Cromoglycic Acid | Acid, Cromoglycic
Chemical Information
Molecular Formula C23H14Na2O11
CAS Registry Number 15826-37-6
SMILES C1=CC2=C(C(=C1)OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)[O-])O)C(=O)C=C(O2)C(=O)[O-].[ Na+].[Na+]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Dry eye06.08.02.001--
Dyspnoea02.11.05.003; 22.02.01.004--
Eye irritation06.04.05.003--Not Available
Eye pain06.08.03.002--
Hordeolum06.04.04.006; 11.01.06.002--Not Available
Instillation site pain12.07.01.008; 08.02.01.008--Not Available
Lacrimation increased06.08.02.004--
Oedema14.05.06.010; 08.01.07.006--Not Available
Rash23.03.13.001--Not Available
Type I hypersensitivity10.01.03.006--Not Available
Conjunctival hyperaemia06.04.01.004--Not Available
Eye oedema06.08.03.013--Not Available
Eye pruritus06.04.05.006--Not Available
The 1th Page    1    Total 1 Pages